Canine ALL patients, in addition to the canine B-cell leukemia cell line, GL-1, contain FLT3 mutations that lead to FLT3 up-regulation and subsequent activation of members of the JAK/STAT and MAP kinase pathways. The gene discussed is SOAT1; the disease is acute lymphoblastic leukemia.